BSE filing, NSE: INDOBORAX. Summary written from the filing by ALFA Finder's alert engine.
Indo Borax & Chemicals Ltd: key numbers
- Share price
- ₹412.00
- Market cap
- ₹1,322 Cr
- Revenue (annual)
- ₹215.4 Cr
- Net profit (annual)
- ₹50.27 Cr
- P/E (TTM)
- 23.5×Sector 34.5×
- Promoter holding
- 38.41%+0.00% QoQ
- FII holding
- 0.10%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indo Borax & Chemicals Ltd
All →Indo Borax & Chemicals Order Update
Indo Borax & Chemicals amended its Share Purchase Agreement dated August 20, 2026, by removing lock-in restrictions and the right of first refusal. This amendment clarifies promoter status.
Indo Borax & Chemicals Debt & Borrowing: ₹225 Cr
Indo Borax created a pledge over 14% of subsidiary Kronox's shares to secure a ₹225 crore term loan. The pledge does not alter the company's control of the subsidiary.
- Value
- ₹225.0 Cr
Indo Borax & Chemicals Annual General Meeting
Indo Borax & Chemicals Ltd issued a notice of postal ballot to seek shareholder approval for creating security on borrowings up to Rs. 400 Crore. Voting will occur via remote e-voting.
Indo Borax & Chemicals Acquisition Worth ₹246.1 Cr
Indo Borax & Chemicals Limited has completed the acquisition of a 64.26% stake in Kronox Lab Sciences Limited for ₹246.12 Crore.
- Value
- ₹246.1 Cr
Indo Borax & Chemicals Acquisition
Indo Borax & Chemicals Limited has completed the acquisition of a 64.26% stake in Kronox Lab Sciences Limited. The transaction involved purchasing 2,38,44,000 equity shares via a share purchase agreement.
Indo Borax & Chemicals Debt & Borrowing: ₹225 Cr
Indo Borax & Chemicals Ltd has availed funding of ₹225 Crore from a lending institution. The capital will finance its acquisition of equity shares in Kronox Lab Sciences Limited.
- Value
- ₹225.0 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.